Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Advances in haemato-oncology: Expert panel discussion

Prof Jesús San Miguel, Prof Umberto Vitolo, Prof Tim Illidge, Dr Francesc Bosch
Advances in haemato-oncology: Expert panel discussion ( Prof Jesús San Miguel, Prof Umberto Vitolo, Prof Tim Illidge, Dr Francesc Bosch )
30 Jan 2015

Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Optimizing survival in advanced prostate cancer: Welcome and introduction

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival

Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015

Optimizing Survival in Advanced Prostate Cancer: Conclusion

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

The DNA damage response and cancer therapy

Dr Christopher Lord, The Institute of Cancer Research, London, UK
The DNA damage response and cancer therapy ( Dr Christopher Lord, The Institute of Cancer Research, London, UK )
6 Jan 2015

UICC 2014 conference report

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
UICC 2014 conference report ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Dec 2014

Comment: SABCS 2014 Highlights

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: SABCS 2014 Highlights ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

Tamoxifen lowered breast cancer rates among high-risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
16 Dec 2014

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014

CLL at ASH 2014: Expert discussion

Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014